Conversation

Notices

1. Embed this notice
   Kit Rhett Aultman (roadriverrail@signs.codes)'s status on Saturday, 06-Apr-2024 07:55:49 JST Kit Rhett Aultman

   in reply to

   • Sepideh
   • Ars Technica

   @sepdroid @arstechnica Stop. The. Presses.

   • Embed this notice
     Sepideh (sepdroid@androiddev.social)'s status on Saturday, 06-Apr-2024 07:55:50 JST Sepideh

     in reply to

     • Ars Technica

     @arstechnica Maybe they shouldn't have been allowed to shake down patients before they could prove that it worked?

   • Embed this notice
     Ars Technica (arstechnica@mastodon.social)'s status on Saturday, 06-Apr-2024 07:55:51 JST Ars Technica

     $158,000 ALS drug pulled from market after failing in large clinical trial

     The drug is now unavailable to new patients; its maker to lay off 70% of employees.

     https://arstechnica.com/science/2024/04/158000-als-drug-pulled-from-market-after-failing-in-large-clinical-trial/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social